UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease

Blood, 2009-05, Vol.113 (21), p.5074-5082

2009

Volltextzugriff (PDF)

Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia

Journal of clinical oncology, 2010-02, Vol.28 (6), p.1047-1053

2010

Volltextzugriff (PDF)

ATM, CTLA4, MNDA, and HEM1 in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia

Clinical cancer research, 2007-09, Vol.13 (18), p.5295-5304

2007

Volltextzugriff (PDF)

Use of Interferon-α in Patients with West Nile Encephalitis: Report of 2 Cases

Clinical infectious diseases, 2005-03, Vol.40 (5), p.764-766

2005

Volltextzugriff (PDF)

Outcomes After Hematopoietic Stem-Cell Transplantation for Hematologic Malignancies in Patients With or Without Advance Care Planning

Journal of clinical oncology, 2007-12, Vol.25 (35), p.5643-5648

2007

Volltextzugriff (PDF)

Myelodysplastic syndromes clinical practice guidelines in oncology

Journal of the National Comprehensive Cancer Network, 2006-01, Vol.4 (1), p.58

2006

Volltextzugriff (PDF)

Refractory CML: not all forms of resistance are equal

Oncology (Williston Park, N.Y.), 2008-04, Vol.22 (4), p.437

Devetten, Marcel

2008

Volltextzugriff (PDF)

Antiretroviral medication prescribing errors are common with hospitalization of HIV-infected patients

Journal of antimicrobial chemotherapy, 2014-01, Vol.69 (1), p.262-267

2014

Volltextzugriff (PDF)

Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

Biology of blood and marrow transplantation, 2009, Vol.15 (1), p.109-117

2009

Volltextzugriff (PDF)

Chronic myelogenous leukemia

Journal of the National Comprehensive Cancer Network, 2007-05, Vol.5 (5), p.474

2007

Volltextzugriff (PDF)

Leukemic Relapse Following MMSC Rescue in a Murine Model of GVHD

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease

Biology of blood and marrow transplantation, 2009-07, Vol.15 (7), p.804-811

2009

Volltextzugriff (PDF)

Utility of a Prognostic Scoring System for Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia

Acta haematologica, 2003-01, Vol.109 (3), p.119-123

2003

Volltextzugriff (PDF)

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

Acta haematologica, 2003-01, Vol.110 (4), p.173-178

2003

Volltextzugriff (PDF)

Graft-versus-host disease: How to translate new insights into new therapeutic strategies

Biology of blood and marrow transplantation, 2004-12, Vol.10 (12), p.815-825

2004

Volltextzugriff (PDF)

Phase I Study of Clofarabine with Standard-Dose Infusional Cytarabine (Ara-C) as Intensive Induction Therapy for Newly-Diagnosed De Novo Acute Myeloid Leukemia in Older Adults Age ≥60 Years

Blood, 2007-11, Vol.110 (11), p.1831-1831

2007

Volltextzugriff (PDF)

Immune Responses in AML Patients Following Vaccination with GRNVAC1, Autologous RNA Transfected Dendritic Cells Expressing Telomerase Catalytic Subunit hTERT

Blood, 2009-11, Vol.114 (22), p.633-633

2009

Volltextzugriff (PDF)

AC220, a Potent, Selective, Second Generation FLT3 Receptor Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study

Blood, 2009-11, Vol.114 (22), p.636-636

2009

Volltextzugriff (PDF)

Phase 1 AML Study of AC220, a Potent and Selective Second Generation FLT3 Receptor Tyrosine Kinase Inhibitor

Blood, 2008-11, Vol.112 (11), p.767-767

2008

Volltextzugriff (PDF)

Multipotentialmesenchymal Stromal Cells (MMSC) Ameliorate Graft versus Host Disease (GVHD) in a Mouse Model, But Major Suppression of GVHD Permits Leukemic Relapse

Stem cell discovery, 2014, Vol.4 (2), p.27-43

2014

Volltextzugriff (PDF)

Mechanism of Alemtuzumab Depletion of T Cells in Stem Cell Products

Blood, 2006-11, Vol.108 (11), p.5176-5176

2006

Volltextzugriff (PDF)

Strategy for Managing Patients with Prior Invasive Aspergillosis through Allogeneic Transplant

Blood, 2006-11, Vol.108 (11), p.5318-5318

2006

Volltextzugriff (PDF)

Effectiveness of Peripheral Blood (PB) Molecular Monitoring by Quantitative RT-PCR (Q-PCR) in Phase II Acute Promyelocytic Leukemia (APL) Trial J0422

Blood, 2008-11, Vol.112 (11), p.1502-1502

2008

Volltextzugriff (PDF)

Minimizing Therapy for Patients with Acute Promyelocytic Leukemia: Efficacy of Single Cycle of Arsenic-Based Consolidation Therapy

Blood, 2008-11, Vol.112 (11), p.1932-1932

2008

Volltextzugriff (PDF)

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST)

Blood, 2007-11, Vol.110 (11), p.2994-2994

2007

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Female
(12)
Male
(12)
Adult
(10)
Middle Aged
(10)
Biological And Medical Sciences
(9)
Hematology
(9)
Medical Sciences
(7)
Immunology
(6)
Oncology
(6)
Prognosis
(6)
Transplantation
(6)
Treatment Outcome
(6)
Hematology, Oncology And Palliative Medicine
(5)
Hematopoietic Stem Cell Transplantation
(5)
Retrospective Studies
(5)
Adolescent
(4)
Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease

Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia

ATM, CTLA4, MNDA, and HEM1 in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia

Use of Interferon-α in Patients with West Nile Encephalitis: Report of 2 Cases

Outcomes After Hematopoietic Stem-Cell Transplantation for Hematologic Malignancies in Patients With or Without Advance Care Planning

Myelodysplastic syndromes clinical practice guidelines in oncology

Refractory CML: not all forms of resistance are equal

Antiretroviral medication prescribing errors are common with hospitalization of HIV-infected patients

Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

Chronic myelogenous leukemia

Leukemic Relapse Following MMSC Rescue in a Murine Model of GVHD

Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease

Utility of a Prognostic Scoring System for Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

Graft-versus-host disease: How to translate new insights into new therapeutic strategies

Phase I Study of Clofarabine with Standard-Dose Infusional Cytarabine (Ara-C) as Intensive Induction Therapy for Newly-Diagnosed De Novo Acute Myeloid Leukemia in Older Adults Age ≥60 Years

Immune Responses in AML Patients Following Vaccination with GRNVAC1, Autologous RNA Transfected Dendritic Cells Expressing Telomerase Catalytic Subunit hTERT

AC220, a Potent, Selective, Second Generation FLT3 Receptor Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study

Phase 1 AML Study of AC220, a Potent and Selective Second Generation FLT3 Receptor Tyrosine Kinase Inhibitor

Multipotentialmesenchymal Stromal Cells (MMSC) Ameliorate Graft versus Host Disease (GVHD) in a Mouse Model, But Major Suppression of GVHD Permits Leukemic Relapse

Mechanism of Alemtuzumab Depletion of T Cells in Stem Cell Products

Strategy for Managing Patients with Prior Invasive Aspergillosis through Allogeneic Transplant

Effectiveness of Peripheral Blood (PB) Molecular Monitoring by Quantitative RT-PCR (Q-PCR) in Phase II Acute Promyelocytic Leukemia (APL) Trial J0422

Minimizing Therapy for Patients with Acute Promyelocytic Leukemia: Efficacy of Single Cycle of Arsenic-Based Consolidation Therapy

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST)

Suchergebnisse filtern